Shareholders to Vote on Expanding Equity Plan to Include Pre-Funded Warrants, Increasing Potential Dilution

summarizeSummary

C4 Therapeutics filed its definitive proxy, revealing a proposal to expand its equity incentive plan by including pre-funded warrants in the evergreen calculation, potentially authorizing an additional 1.1 million shares for future awards.

check_boxKey Events

• Proposed Equity Plan Amendment

  Shareholders will vote on amending the 2020 Stock Option and Incentive Plan to include shares underlying outstanding pre-funded warrants in the 'evergreen' provision calculation. This would increase the annual share reserve for equity awards.

• Significant Potential Dilution

  The amendment, if approved, would authorize an additional 1,126,325 shares for future issuance under the plan, representing a substantial increase in potential dilution for existing shareholders.

• Annual Meeting Details

  The annual meeting will be held virtually on June 24, 2026, where shareholders will also vote on the election of three Class III directors, an advisory vote on executive compensation, and the ratification of KPMG LLP as the independent auditor.

• Company's Rationale

  The company states the amendment is necessary to maintain a competitive position in attracting and retaining highly skilled personnel, aligning with its long-term growth strategy.

auto_awesomeAnalysis

C4 Therapeutics has filed its definitive proxy statement for its annual meeting on June 24, 2026. The most significant proposal is an amendment to the 2020 Stock Option and Incentive Plan. This amendment seeks to include shares underlying outstanding pre-funded warrants in the calculation for the plan's 'evergreen' provision, which automatically increases the share reserve annually. If approved, this change would authorize an additional 1,126,325 shares for future equity awards, representing a notable potential dilution for existing shareholders. While the company states this is crucial for attracting and retaining talent, it expands the pool for future stock-based compensation. Other proposals include the routine election of directors, an advisory vote on executive compensation, and the ratification of the auditor.